March 20, 2024Open Access

FIGURE 4 from Autophagy Inhibition–induced Cytosolic DNA Sensing Combined with Differentiation Therapy Induces Irreversible Myeloid Differentiation in Leukemia Cells

View Full Paper

Ask AI

Bookmark

Authors

TBTomohisa BabaKanazawa University UTUtano TomaruHokkaido University Hospital AHAtsushi HiraoKanazawa University

Discussion

Member takes

Implication

Preclinical study demonstrates synergistic myeloid differentiation in FLT3-ITD leukemia cells treated with MRT and quizartinib, indicating a differentiation therapy approach.

Key Points

Myeloid differentiation occurs synergistically in FLT3-ITD leukemia cells following combined autophagy inhibition and quizartinib treatment, overcoming FGF2-mediated resistance.
CD11b expression increases significantly under 5 nmol/L quizartinib and 1 µmol/L MRT, demonstrating potent induction of mature cell markers despite the presence of FGF2.
Highlights potential for cytosolic dna sensing pathways to overcome resistance in leukemia cells, though findings remain limited to in vitro cell culture models.

Cite This Study

Baba et al. (2024) studied this question.

synapsesocial.com/papers/68e733bdb6db6435876ad381 https://doi.org/10.1158/2767-9764.25444127

View Full Paper

Ask AI

Bookmark

Implication

Preclinical study demonstrates synergistic myeloid differentiation in FLT3-ITD leukemia cells treated with MRT and quizartinib, indicating a differentiation therapy approach.

FIGURE 4 from Autophagy Inhibition–induced Cytosolic DNA Sensing Combined with Differentiation Therapy Induces Irreversible Myeloid Differentiation in Leukemia Cells

Discussion

Member takes

Implication

Key Points

Cite This Study

FIGURE 4 from Autophagy Inhibition–induced Cytosolic DNA Sensing Combined with Differentiation Therapy Induces Irreversible Myeloid Differentiation in Leukemia Cells

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider